Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial, ACROINNOVA 1
Pamela U. Freda, Agneta Svedberg, Pınar Kadıoğlu, Pietro Maffei et al.
Citations
16 citations
Journal
The Journal of Clinical Endocrinology & Metabolism
Topics
Pituitary Gland Disorders and Treatments
Field-Weighted Citation Impact (FWCI)
5.72
article
Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial, ACROINNOVA 1
Pamela U. Freda, Agneta Svedberg, Pınar Kadıoğlu, Pietro Maffei, Joanna L. Spencer-Segal, Diego Ferone, Jochen Seufert, Fredrik Tiberg, Julie Martha Silverstein, Alexander Dreval, Federico Gatto, Laurence Katznelson, Elena Isaeva, Maria Harrie
article en
16 citations
Abstract
No abstract available for this paper.
Publication Tag
The Journal of Clinical Endocrinology & MetabolismVol. 110(6)
Institutions
University of Padua (IT), University of Freiburg (DE), Washington University in St. Louis (US), University of Michigan (US), Michigan CardioVascular Institute (US), Istanbul University-Cerrahpaşa (TR), Moscow Regional Research Institute of Obstetrics and Gynecology (RU), Stanford Medicine (US), Regional Clinical Research (US), Ospedale Policlinico San Martino (IT), Columbia University (US), Stanford University (US)